GSK Panadol referral
July 26, 2013
GLAXOSMITHKLINE is referring
patients to their local pharmacist
for advice on analgesia for kids,
in the light of Children’s Panadol
1-5 years suspension being “out
of stock for a limited period” due
to the Reckitt Benckiser patent
challenge over the product’s dosing
device (PD 12 Jun, 19 Jul).
GSK gm consumer healthcare
ANZ, Vincent Cotard, stressed
that there are no safety, efficacy
or formulation issues, with the
company “working hard to ensure
that Children’s Panadol 1-5 years
suspension is available again as
soon as possible”.
Only the 1-5 years suspension
is affected , with other Children’s
Panadol products still available.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jul 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jul 13